In acute myeloid leukemia (AML), IL1R2 gene expression was associated with bad prognosis (75), in ovarian cancer, IL1R2 was upregulated in recurrent compared to primary cancer (76) and in prostate the molecule was expressed in prostatic cancer cells but not in normal cells (77). Here, IL1R2 is linked to prostate carcinoma.